Back

Assessment of the CHA2DS2-VASc score in predicting new onset atrial fibrillation during hospitalization for community-acquired pneumonia.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Atrial fibrillation: epidemiology, prognosis, outcome Prevalence and Incidence of Atrial Fibrillation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Filippo Pieralli

Careggi University Hospital, Florence (Italy)

9 More presentations in this session

Presentation thumbnail
Daily heart rate variability predicts heart failure events in patients with permanent atrial fibrillation.
Doctor J. Oikawa (Sagamihara, JP)
Abstract
Presentation thumbnail
The current pattern and determinant of oral anticoagulation in Korean patients with nonvalvular atrial fibrillation: analysis of a multicenter registry (Comparision study of Drugs for symptom control
Doctor J. Kim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Burden of comorbidities, quality of anticoagulation control and outcomes: an analysis from the AFFIRM study
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Impact of atrial fibrillation on patients admitted with hip fracture undergoing surgery: outcomes in the US (2005-2014)
Doctor K. Agnihotri (Little Rock, US)
Abstract Slides
Presentation thumbnail
Influence of diabetes mellitus on survival of patients with atrial fibrillation - A population-based study
Doctor S. Patlolla (Rochester, US)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Atrial fibrillation: epidemiology, prognosis, outcome

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources